Targets with BC > 40.153, CC > 0.063, and DC > 15.693 were considered core targets, resulting in a total of eight key targets, including Jun proto‐oncogene (JUN), TNF, AKT serine/threonine kinase 1 (AKT1), interleukin 1 beta (IL1B), peroxisome proliferator‐activated receptor gamma (PPARG), mitogen‐activated protein kinase 8 (MAPK8), caspase 3 (CASP3), and prostaglandin‐endoperoxide synthase 2 (PTGS2) (Figure 6B). This evidence concerns the gene AKT1 and breast cancer.